AHA Scientific Sessions 2023 Late-Breaking Science Coverage

Published: 30 October 2023

  • Views:

    Views Icon 2665

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Stay up-to-date with the latest data in cardiovascular science with the help of renowned experts and emerging voices who offer concise summaries, in-depth discussions, and critical reviews to keep you informed.

 

In their regular View from the Thoraxcenter series, Prof Van Mieghem and Dr Daemen provide valuable insights into the most anticipated trials of AHA 23. With their keen awareness of cardiovascular innovation, they offer concise perspectives on late-breaking data.

 

Dr Harriette Van Spall returns with her Late-breaker Discussion series featuring ground-breaking research presented at Scientific Sessions. Join her and lead investigators as they discuss methodology, results, and impact on patient care.

 

Watch our Expert interviews for late-breaking science methodology, results and implications for practice and research in under 10 minutes.

 

Delve into the personal motivations of some of the investigators, and gain valuable insights and advice for early career researchers in our Behind the Heart series. These short videos offer an opportunity to look beyond scientific achievements and connect on a more personal level.

More from this programme

Part 1

View from the Thoraxcenter

In their regular View from the Thoraxcenter series, Prof Van Mieghem and Dr Daemen provide valuable insights into the most anticipated trials of AHA 23. 

2 sessions
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up Watch now
View from the Thoraxcenter: AHA 23 Late-breaking Science Preview Watch now

Part 2

Late-Breaker Discussions with Harriette Van Spall

Dr Harriette Van Spall, recipient of 2022's AHA Dr. Nanette K. Wenger Award, returns with her Late-breaker Discussion series featuring ground-breaking research presented at Scientific Sessions. Join her and lead investigators as they discuss methodology, results, and impact on patient care.

4 sessions
AHA 23 Late-Breaker Discussion: The ARIES HM3 Clinical Trial Watch now
AHA 23 Late-Breaker Discussion: The DAPA-MI Trial Watch now
AHA 23 Late-Breaker Discussion: Hypertension Treatment in Nigeria Program Watch now
AHA 23 Late-Breaker Discussion: The SELECT Trial Watch now

Part 3

Expert Interviews

Watch our Expert interviews for late-breaking science methodology, results and implications for practice and research in under 10 minutes.

11 sessions
I-CLAS: Arrhythmic Risk in Biventricular Pacing Vs Left Bundle Branch Area Pacing Watch now
ECLS-SHOCK: Impact of Cardiac Arrest on the Efficacy of ECLS Patients Watch now
Automated Referral to Centralized Pharmacy Services for Evidence-Based Statin Initiation in High-Risk Patients Watch now
Nicotinamide Riboside in PAD for Improved Walking Watch now
SPECIAL: Ultrasound-assisted Thrombolysis Vs Pulmonary Embolectomy for PE Watch now
Screening for Peripartum Cardiomyopathies Using an AI Enanced Digital Stethoscope Watch now
ORFAN: AI Technology to Improve Risk Stratification of Patients without CAD Undergoing CCTA Watch now
KABUKI: Edoxaban in Patients with Chronic Thromboembolic Pulmonary Hypertension Watch now
JEWEL-IDE: Jewel P-WCD in Pts at High Risk of Cardiac Arrest Watch now
Screening for Peripartum Cardiomyopathies Using an AI Enanced Digital Stethoscope Watch now
Automated Referral to Centralized Pharmacy Services for Evidence-Based Statin Initiation in High-Risk Patients Watch now

Part 4

Highlights

3 sessions
Preventive Cardiology Highlights in 2023 Watch now
3 Trials That Will Change My Practice With Dr Parwani Watch now
3 Trials That Will Change My Practice With Dr Itchhaporia Watch now

Part 5

Behind the Heart

3 sessions
Solving Problems with Dr Pugazhendi Vijayaraman Watch now
Advice for Early-Career Researchers With Dr Demilade Adedinsewo Watch now
Making a Difference with Dr Alexander Fanaroff Watch now

About the episode

AHA 23 - Dr Dipti Itchhaporia (Hoag Heart and Vascular Institute, US), interventional cardiologist and Past President of the American College of Cardiology (ACC) highlights the top three late-breaking science trials from the 2023 AHA Scientific Sessions with the potential to change medical practices.

Trials discussed in detail include:
SELECT: Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
ARIES-HM3: Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure
ORBITA-2: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina

For more content from #AHA23 head to the Late-Breaking or the CardioNerds Conference Scholars Collection.

Recorded on-site at AHA Scientific Sessions 23, Philadelphia.

Editor: Mirjam Boros

Videographer: Daniel Brent

Faculty Biographies

Dipti Itchhaporia

Dipti Itchhaporia

Interventional Cardiologist

Dr Dipti Itchhaporia, an interventional cardiologist, holds the Eric & Sheila Samson Endowed Chair in Cardiovascular Health and serves as the director of disease management for the Hoag Heart and Vascular Institute. Additionally, she is an Associate Clinical Professor at the University of California, Irvine, and a Past President of the American College of Cardiology (ACC).

Dr Itchhaporia completed her residency in internal medicine at Stanford University Medical Center. She then joined the General Medicine Faculty at the University of California, San Francisco (UCSF) but eventually pursued a cardiology fellowship at Georgetown University and an interventional cardiology fellowship at Stanford University. She is a fellow of the American College of Cardiology, the European Society of Cardiology, and an honorary member of the British Cardiovascular Society.

View full profile

Comments

You must be to comment. If you are not registered, you can register here.